Adbry side effects
Eczema relief with Adbry
It can be frustrating when your is still not under control. Adbry® (tralokinumab-ldrm) works inside the body to help get clearer skin and control the unbearable itch for the long-term. Adbry was used in 2 clinical trials for up to 1 year, and 1 trial for up to 8 months. Talk to your healthcare professional to see if Adbry is right for you.
Clearer skin
Adbry helped visibly improve the look and texture of skin at 4 months.

Not an actual patient.
Individual results may vary.

Not an actual patient.
Individual results may vary.
Itch less
Adults using Adbry experienced significantly less itch.
Maintained results
In all 3 clinical trials where adults used Adbry every other week, more patients experienced relief at 4 months, and maintained relief through the end of the trials, either at 8 months or 12 months.

Not an actual patient. Individual results may vary.
How was Adbry studied in clinical trials?
Adbry was studied in 3 separate clinical trials of almost 2,000 adults aged 18 and older with moderate-to-severe (). People in the trials injected 2 prefilled syringes every other week.
TRIAL 1: 601 people used Adbry; 197 used
TRIAL 2: 577 people used Adbry; 193 used
TRIAL 3: 243 people used Adbry + ; 123 used +
Clearer skin was measured in 2 ways:
- The percentage of people who saw CLEAR OR ALMOST CLEAR SKIN
- The percentage of people who saw a 75% OR BETTER IMPROVEMENT IN SKIN

Not an actual patient.
Individual results may vary.
Across Trials 1, 2, and 3, more people using Adbry saw a 90% or better improvement in their skin compared to those using .